Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > Large lawsuit filed against Liminal for some $700,000,000

<< Previous

Bullboard Posts

Next >>

Comment by stockbuphoonon Aug 10, 2021 11:16am

36 Views

Post# 33678125

RE:RE:RE:RE:RE:RE:RE:RE:RE:Large lawsuit filed against Liminal for some $700,000,000

There is 650 plaintiffs to the lawsuit!!!!

you continue to mislead. There are plenty of stocks to pump. This one is over as thomvest will hide every sense of value in any molecule and play the long, long game. They can wait 5 years to sell 4050 as it is unprecedented molecule working on fibrosis. You'll never see the value here. CEO is part of it and so is President to keep their jobs.